JPS5857395A - 2-amino-6-alkoxycarbonylmethylpurine nucleoside - Google Patents
2-amino-6-alkoxycarbonylmethylpurine nucleosideInfo
- Publication number
- JPS5857395A JPS5857395A JP56156892A JP15689281A JPS5857395A JP S5857395 A JPS5857395 A JP S5857395A JP 56156892 A JP56156892 A JP 56156892A JP 15689281 A JP15689281 A JP 15689281A JP S5857395 A JPS5857395 A JP S5857395A
- Authority
- JP
- Japan
- Prior art keywords
- residue
- amino
- nucleoside
- compound
- deoxyribose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Saccharide Compounds (AREA)
Abstract
Description
【発明の詳細な説明】
本発明は、新規化合物の2−アミノ−6−アルコキシカ
ルボニルメチルプリンヌクレオシドおよびその製造法に
関するものである。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a novel compound 2-amino-6-alkoxycarbonylmethylpurine nucleoside and a method for producing the same.
本発明の目的化合物である2−アミノ−6−アルコキシ
カルボニルメチルプリンヌクレオシドは次の一般式〔1
〕で表わされる化合物である。The object compound of the present invention, 2-amino-6-alkoxycarbonylmethylpurine nucleoside, has the following general formula [1
] This is a compound represented by
3
該式中 R1は低級アルキル基(メチル、エチル、プロ
ピル、ブチルなど)、R2は水素または保護基、R3は
保護基を有することあるリボース残基、2−デオキシリ
ボース残基、アラビノース残基、キシロース残基または
3−デオキノリボース残基を示す。ここで保護基として
は、アセチル、ブチリル、ベンゾイルなどのアンル基、
インプロピリデン、エチリデンなとのアルキリデン基、
ベンジリデンなどのアルアルキリデン基、トリチル、ベ
ンジルなどのアルアルキル基、メトキノメチレン、エト
キンメチレン、エトキシエチレンなどのアルコキンアル
キリデン基、テトラヒドロピラニル基なとのヌクレオシ
ド化学分野で使用されうるもので、本発明化合物の合成
反応もしくは応用反応に好適なものが例示される。3 In the formula, R1 is a lower alkyl group (methyl, ethyl, propyl, butyl, etc.), R2 is hydrogen or a protecting group, R3 is a ribose residue, a 2-deoxyribose residue, an arabinose residue, which may have a protecting group, Indicates a xylose or 3-deoquinolibose residue. Examples of protective groups include anru groups such as acetyl, butyryl, and benzoyl;
Alkylidene groups such as impropylidene and ethylidene,
It can be used in the field of nucleoside chemistry, including aralkylidene groups such as benzylidene, aralkyl groups such as trityl and benzyl, alkoxyalkylidene groups such as methquinomethylene, ethquinmethylene, and ethoxyethylene, and tetrahydropyranyl groups. Those suitable for the synthetic reaction or applied reaction of the compound of the present invention are exemplified.
本発明化合物は文献未記載の新規化合物であり、R1の
アルコール残基をエステル結合の加水分解により除去し
、脱炭酸処理することにより、既知化合物2−アミノ−
6−メチルブリンヌクレオンドに導くことができるほか
、アンモニア処理することによりアデニルデアミナーゼ
阻害活性を有する新規物質2−アミノ−6−カルバモイ
ルメチル体を得ることができる。このように本発明化合
物は種々の生理活性か期待される6CC置換グアソノヌ
クレオシド誘導の合成中間体として有用である。The compound of the present invention is a new compound that has not been described in any literature, and by removing the alcohol residue of R1 by hydrolysis of the ester bond and decarboxylating it, the known compound 2-amino-
In addition to being able to lead to a 6-methylbrin nucleond, a 2-amino-6-carbamoylmethyl compound, a new substance having adenyl deaminase inhibitory activity, can be obtained by treatment with ammonia. As described above, the compounds of the present invention are useful as synthetic intermediates for 6CC-substituted guasononucleoside derivatives that are expected to exhibit various physiological activities.
本発明化合物は、一般式〔■〕
3
〔式中、R2およびR3は前記一般式〔I〕の場合と同
意義、R4はアルキル基またはアリール基を示す。〕で
表わされる2−アミノ−6−アルキルまたはアレーンス
ルホニルプリンヌクレオシドと、塩基の存在下で一般式
rlll)
CH3COCH2COORI CI! )〔式中、R
1は前記一般式〔1〕との場合と同意義。〕で表わされ
るアセト酢酸アルキルエステルとを反応させることによ
り製造することができる。The compound of the present invention has the general formula [■] 3 [wherein R2 and R3 have the same meanings as in the above general formula [I], and R4 represents an alkyl group or an aryl group. ] and a 2-amino-6-alkyl or arenesulfonyl purine nucleoside of the general formula rllll) in the presence of a base CH3COCH2COORI CI! ) [wherein, R
1 has the same meaning as in general formula [1] above. It can be produced by reacting with acetoacetic acid alkyl ester represented by ].
原料化合物である一般式〔I)化合物におけるR4のア
ルキル基または了り−ル基としてはメチル、エチル、ブ
チル、4−メチルフェニル、4−ブロモフェニル、2,
4.6−)リメチルフェニルなどが具体的に例示できる
。The alkyl group or aryl group of R4 in the compound of general formula [I] which is a raw material compound includes methyl, ethyl, butyl, 4-methylphenyl, 4-bromophenyl, 2,
Specific examples include 4.6-)limethylphenyl.
アセト酢酸アルキルエステルとの反応は、アセト酢酸ア
ルキルエステルから塩基によりプロトノを引き抜きカル
バニオンを生成させ、これを原料化合物に反応させるこ
とにより行われる。The reaction with acetoacetate alkyl ester is carried out by extracting protons from acetoacetate alkyl ester with a base to generate a carbanion, and reacting this with the raw material compound.
塩基としては、水素化ナトリウム、n−ブチルカリウム
、フェニルカリウム、n−ブチルリチウム、フェニルナ
トリウム、カリウムアミド、ナトリウムアミドなどが適
用されうる。As the base, sodium hydride, n-butylpotassium, phenylpotassium, n-butyllithium, phenylsodium, potassium amide, sodium amide, etc. can be applied.
反応は、通常、溶媒中で行われ、溶媒としては非プロト
ン性極性溶媒が使用されつる。具体的には、たとえばテ
トラヒドロフラン、ヘキサメチルホスホロアミド、ジメ
チルホルホキンド、ジメチルホルムアミド、ジメチルア
セトアミド、ジメトキンエタン、ジオキサン、アセトニ
トリルなとを用いればよい。また、反応溶媒中に18−
クラウン−6なとの大環状ポリエーテル類のような求核
試薬の反応性を増大させるものを反応促進剤として共存
させることも有効である。The reaction is usually carried out in a solvent, and an aprotic polar solvent is used as the solvent. Specifically, for example, tetrahydrofuran, hexamethylphosphoramide, dimethylformoquinde, dimethylformamide, dimethylacetamide, dimethquinethane, dioxane, acetonitrile, etc. may be used. In addition, 18-
It is also effective to coexist as a reaction accelerator a substance that increases the reactivity of the nucleophilic reagent, such as macrocyclic polyethers such as crown-6.
反応の温度条件には特に制約されないが、通常室温〜溶
媒還流温度の加熱条件下で行われる。反応待間は、反応
溶媒および塩基の種類、ならひ1こ反応温度などにより
異なるか、通常数十分〜十数ド化学分野で利用される常
法によればよい。たとえば、吸着カラムクロマトグラフ
ィー、分配、再結晶などの分離精製手段を適宜に応用し
て実施することができる。Although the temperature conditions for the reaction are not particularly limited, the reaction is usually carried out under heating conditions ranging from room temperature to the solvent reflux temperature. The reaction time may vary depending on the type of reaction solvent and base, the reaction temperature, etc., or may be according to a conventional method used in the chemical field. For example, separation and purification means such as adsorption column chromatography, distribution, and recrystallization can be applied as appropriate.
本発明化合物からエステル加水分解処理、さらに脱炭酸
処理を経て2−アミ/−6−メチルプリンヌクレオシド
に導くことかできる。2−アミノ−6−メチルプリンヌ
クレオシドはさらに2−アミン基の置換反応により種々
の生理活性を有する6−メチルプリンヌクレオシドの2
−置換誘導体の重要な合成中間体となるものである。エ
ステル加水分解処理は通常の方法、たとえば加熱処理、
アルカリ処理、または酸処理により行えばよし1゜また
、脱炭酸処理は、酸処理、あるいは触媒(たとえば無水
安息香酸、N−ブロムスクシンイミド(N B S 入
銅粉、キノリンなど)処理によればよい。The compound of the present invention can be led to 2-amino/-6-methylpurine nucleoside through ester hydrolysis treatment and further decarboxylation treatment. 2-Amino-6-methylpurine nucleoside can be further converted into 2-methylpurine nucleosides which have various physiological activities by substitution reaction of 2-amine group.
-It is an important synthetic intermediate for substituted derivatives. Ester hydrolysis treatment can be carried out using conventional methods such as heat treatment,
Alkali treatment or acid treatment may be used.1゜Also, decarboxylation treatment may be performed by acid treatment or catalyst treatment (for example, benzoic anhydride, N-bromsuccinimide (NBS-containing copper powder, quinoline, etc.) treatment). .
以下、本発明化合物の製造例を示す実施例、およびその
応用例を示す参考例を挙げて、本発明のより具体的な説
明とする。EXAMPLES Hereinafter, the present invention will be more specifically explained by giving examples showing production examples of the compounds of the present invention and reference examples showing application examples thereof.
実施例 1
50%水素化ナトリウム608gのテトラヒドロフラン
70xtl@’118液に、アセト酢酸エチルエステル
248qとテトラヒドロフラン15s+/の混液を滴下
し、透明な溶液とした。この溶液を、0(6)−p−ト
ルエンスルホニル−N+21.0f2)、 Ofg+。Example 1 A mixed solution of 248q of acetoacetic acid ethyl ester and 15s+ of tetrahydrofuran was added dropwise to a solution of 608g of 50% sodium hydride in 70xtl@'118 of tetrahydrofuran to obtain a transparent solution. This solution was converted to 0(6)-p-toluenesulfonyl-N+21.0f2), Ofg+.
(]5つ一テトラアセチルグアノノン385gをテトラ
ヒドロフラン290 mlに溶解させた液に加え、25
時間加熱還流した。(5) Add 385 g of tetraacetylguanonone to 290 ml of tetrahydrofuran, add 25
The mixture was heated to reflux for an hour.
反応液を冷却後、酢酸で中和し、減圧上濃縮乾固した。After cooling the reaction solution, it was neutralized with acetic acid and concentrated to dryness under reduced pressure.
残渣を水とクロロホルムに分配し、クロロホルム層を硫
酸マグネシウムで乾燥した後、ソリ力ゲル1.5 kq
のカラムに吸着させ、クロロホルム−メタノール(99
:1)で溶出し、溶出液を濃縮乾固して2−アセトアミ
ド−6−ニトキソカルポニルメチルー9−(2,8,5
−)リー〇−アセチルーB−D−リボフラノシル)プリ
ン20gを得た(収率60%)。After partitioning the residue between water and chloroform and drying the chloroform layer with magnesium sulfate, 1.5 kq
was adsorbed onto a column of chloroform-methanol (99%).
:1), and the eluate was concentrated to dryness to yield 2-acetamido-6-nitoxocarponylmethyl-9-(2,8,5
20 g of (yield: 60%) was obtained.
紫外線吸収スペクトル
eOH
λmax 325 nm 、 239 nm質
量分析スペクトル mle 521 (M+)核磁気
共鳴スペクトル(CDCl8) δ、 ppm8、
85 (I H,b、s 、NH)8.04(IH,s
、8−H)
6、19 (lH,d、 1’−H)5、86 (I
H,m、 2’−H)5、75 (I H,m、
3’−H)4、42 (3H,m、 4’−H,5’
−H)4、12 (2H,s、 6−CH214,1
8(2H,(1,−QC恥CH3)1、26 (8H,
t、 −0C82C勺)実施例 2
0f61−p−トルエンスルホニル−NF2+、 O(
3′1゜0[5クートリアセチル−2′−デオキングア
ノシン2.4gのテトラヒドロフラン20IIIf溶液
にアセト酢酸エチルエステル1719と50%水素化ナ
トリウム0.42 gとから調製したカルバニオンテト
ラヒドロフラン溶液6 wlを加え、1時間加41IV
還流した
反応液を冷却後、酢酸で中和し、減圧上濃縮乾固した。Ultraviolet absorption spectrum eOH λmax 325 nm, 239 nm Mass spectrometry spectrum mle 521 (M+) Nuclear magnetic resonance spectrum (CDCl8) δ, ppm8,
85 (I H, b, s , NH) 8.04 (I H, s
, 8-H) 6, 19 (lH, d, 1'-H) 5, 86 (I
H, m, 2'-H)5, 75 (I H, m,
3'-H) 4, 42 (3H, m, 4'-H, 5'
-H)4,12 (2H,s, 6-CH214,1
8 (2H, (1, -QC shame CH3) 1, 26 (8H,
t, -0C82C) Example 2 Of61-p-toluenesulfonyl-NF2+, O(
3'1゜0[5Cutriacetyl-2'-deokinganosine 2.4 g in tetrahydrofuran 20IIIf solution was mixed with 6 wl of a carbanion tetrahydrofuran solution prepared from acetoacetic acid ethyl ester 1719 and 50% sodium hydride 0.42 g. In addition, 1 hour plus 41 IV
The refluxed reaction solution was cooled, neutralized with acetic acid, and concentrated to dryness under reduced pressure.
得られた残渣をクロロポルムで抽出し、抽出液をノリ力
ゲル]00&のカラムクロマトに吸着分離し、2−アセ
トアミド−6−ニトキ7カルボニルメチルー9−(3,
5−ジー〇−アセチルーβ−D−2−デオキノリボフラ
ノンル)−プリン682 mgを得た。The obtained residue was extracted with chloroporm, and the extract was adsorbed and separated on a column chromatograph using Nori-Gel]00& to obtain 2-acetamido-6-nitoki7carbonylmethyl-9-(3,
682 mg of 5-di0-acetyl-β-D-2-deoquinolibofuranone-purine was obtained.
紫外線板−収スベクトル λ:謀H296nm核磁気共
鳴スペクトル (DMSO−d6)δppm8、88
(I H,b、s、 NH)8.09 L IH
,s、 H−B )6.87(1B、t、H−1’
)
5.2〜5.5 (I H,m、 H−8′)4、37
(8H,m、 H−4’、 H−5’)4、12
(2H,s、 6−CH2)2.5〜3.0 (2
8,m、 H−2’ )応用例 1
2−アセトアミド−6−ニトキシカルポニルメチルー9
−(2,8,5−トリー〇−アセチルーβ−D−リボフ
ラノシル)プリン16.59をIN−水酸化ナトリウム
(50%エタノール)に溶解させ、室温で25時間放置
した。反応液に陽イオン交換樹脂(ダイヤイオンPK−
216.H型)880 telを加え、室温で2時間撹
拌した。樹脂を濾過し、0.15 N−アンモニア水1
.57?て洗い、濾液と洗液を合せて減圧濃縮した。残
渣を1.51水溶液とし、陽イオン交換樹脂(ダイヤイ
オンPK−216.H型) 800 mlのカラムに吸
着させ、015N−アンモニア水て溶出した。溶出液を
減圧濃縮し、残渣を水から再結晶し、2−アミノ−6−
メチル−9−β−D−リボフラノシルプリンの針状結晶
4.5gを得た(収率508%)。Ultraviolet plate - convergence vector λ: H296nm nuclear magnetic resonance spectrum (DMSO-d6) δppm8,88
(I H, b, s, NH) 8.09 L IH
, s, H-B) 6.87 (1B, t, H-1'
) 5.2-5.5 (I H, m, H-8') 4, 37
(8H, m, H-4', H-5') 4, 12
(2H,s, 6-CH2)2.5~3.0 (2
8, m, H-2') Application example 1 2-acetamido-6-nitoxycarponylmethyl-9
-(2,8,5-tri0-acetyl-β-D-ribofuranosyl)purine 16.59 was dissolved in IN-sodium hydroxide (50% ethanol) and left at room temperature for 25 hours. Cation exchange resin (Diaion PK-
216. H type) 880 tel was added, and the mixture was stirred at room temperature for 2 hours. Filter the resin and add 0.15N-ammonia water 1
.. 57? The filtrate and washing liquid were combined and concentrated under reduced pressure. The residue was made into a 1.51 aqueous solution, adsorbed on an 800 ml column of cation exchange resin (Diaion PK-216.H type), and eluted with 0.15N aqueous ammonia. The eluate was concentrated under reduced pressure, and the residue was recrystallized from water to give 2-amino-6-
4.5 g of needle-like crystals of methyl-9-β-D-ribofuranosylpurine were obtained (yield 508%).
融点 159℃
元素分析 C11HI5N504・1/2 H2Oと
して計算値(ト): C,45,52、H,5,56;
N、 24.L(実験値圀: C,45,89;H,5
,24;N、 24.52質量分析スペクトル ml
e 2824M+)紫外線吸収スペクトル nm
λ?1.11a’x−H0’ 809.243 (
sh)、229λ?rl>N−NaOH297,229
核磁気共鳴スヘクトル(DMSO−d6)δppm8.
14(IH,s、8−H)
6、28 (2H,b、s、 NH2)5、78 (
I H,d、 1’−H)2.4’1(8H,s、6
−CHB)
応用例 2
2−アセトアミド−6−ニドキシカルボニルメチルー9
−(2,8,5−トリー〇−アセチルーβ−D−リボフ
ラノシル)プリン1.27りを無水飽和アンモニアメタ
ノール1’00#I/に溶解させた後、室温で3日間放
置した。反応液を濃縮乾固し、残渣を水から再結晶して
2−アミノ−6−カルパモイルメチルー9−β−D−リ
ボフラノシルプリンの針状結晶607 mlを得た(収
率77.5%)。Melting point 159°C Elemental analysis C11HI5N504・1/2 Calculated value as H2O (g): C, 45,52, H, 5,56;
N, 24. L (experimental value: C, 45, 89; H, 5
,24;N, 24.52 mass spectrometry spectrum ml
e 2824M+) Ultraviolet absorption spectrum nm λ? 1.11a'x-H0' 809.243 (
sh), 229λ? rl>N-NaOH297,229
Nuclear magnetic resonance spectrum (DMSO-d6) δppm8.
14 (IH, s, 8-H) 6, 28 (2H, b, s, NH2) 5, 78 (
I H, d, 1'-H) 2.4'1 (8H, s, 6
-CHB) Application example 2 2-acetamido-6-nidoxycarbonylmethyl-9
-(2,8,5-tri〇-acetyl-β-D-ribofuranosyl)purine was dissolved in 1'00 #I of anhydrous saturated ammonia methanol and then allowed to stand at room temperature for 3 days. The reaction solution was concentrated to dryness, and the residue was recrystallized from water to obtain 607 ml of needle-like crystals of 2-amino-6-carpamoylmethyl-9-β-D-ribofuranosylpurine (yield: 77. 5%).
融点 139°C
元素分析 C!2H16N6o5・1/2H2oトシ
テ計算値顛: C,48,24;)I、 5.14 ;
N、 26.40実験値(ト): C,43,Ll ;
H,4,95iN、 25.85紫外線吸収スペクトル
nm
化? 306.244.221
λo、tN−HCI 317.250 (sh)、
226ax
λ01N−NaoH305,244fsh)、 227
ax
核磁気共鳴スペクトル(DMSO−d6)δppm8.
18(IH,s、8−H)Melting point 139°C Elemental analysis C! 2H16N6o5・1/2H2o calculation value: C, 48, 24;) I, 5.14;
N, 26.40 Experimental value (g): C, 43, Ll;
H, 4,95iN, 25.85 ultraviolet absorption spectrum nm? 306.244.221 λo, tN-HCI 317.250 (sh),
226ax λ01N-NaoH305, 244fsh), 227
ax nuclear magnetic resonance spectrum (DMSO-d6) δppm8.
18 (IH, s, 8-H)
Claims (1)
基、R3は保護基を有することあるリボース残基、2−
デオキシリボース残基、アラビノース残基、キシロース
残基または3−デオキシリボース残基を示す。〕で表わ
される2−アミン−6−アルコキシカルボニルメチルシ
リ、ンヌクレオシド。 2)一般式CM〕 3 〔式中、R2は保護基、R3は保護基を有することある
リボース残基、2−デオキシリボース残基、アラビノー
ス残基、キシロース残基または3−デオキシリボース残
基、R4はアルキル基またはアリール基を示す。〕で表
わされる2−アミノ−6−アルキルまたはアレーンスル
ホニルプリンヌクレオシドと、塩基の存在下て一般式r
lDCHaCOCH2COOR1〔1) 〔式中、R1は低級アルキル基を示す。〕で表わされる
アセト酢酸アルキルエステルとを反応させ、一般式〔1
〕 〔式中、R1、R2、R8は前記と同意義。〕で表わさ
れる2−アミノ−6−アルコキシカルボニルメチルプリ
ンヌクレオシドを合成することを特徴とする2−アミノ
−6−アルコキシカルボニルメチルプリンヌクレオシド
の製造法。[Claims] l) General formula [1] 3 [In the formula, R1 is a lower alkyl group, R2 is hydrogen or a protecting group, R3 is a ribose residue that may have a protecting group, 2-
Indicates a deoxyribose, arabinose, xylose or 3-deoxyribose residue. ] 2-amine-6-alkoxycarbonylmethylsilicon nucleoside. 2) General formula CM] 3 [wherein R2 is a protecting group, R3 is a ribose residue, 2-deoxyribose residue, arabinose residue, xylose residue or 3-deoxyribose residue, which may have a protecting group; R4 represents an alkyl group or an aryl group. 2-amino-6-alkyl or arenesulfonylpurine nucleoside represented by
lDCHaCOCH2COOR1 [1] [In the formula, R1 represents a lower alkyl group. ] is reacted with acetoacetic alkyl ester represented by the general formula [1
] [In the formula, R1, R2, and R8 have the same meanings as above. A method for producing 2-amino-6-alkoxycarbonylmethylpurine nucleoside, which comprises synthesizing 2-amino-6-alkoxycarbonylmethylpurine nucleoside represented by the following.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP56156892A JPS5857395A (en) | 1981-09-30 | 1981-09-30 | 2-amino-6-alkoxycarbonylmethylpurine nucleoside |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP56156892A JPS5857395A (en) | 1981-09-30 | 1981-09-30 | 2-amino-6-alkoxycarbonylmethylpurine nucleoside |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5857395A true JPS5857395A (en) | 1983-04-05 |
JPH0153678B2 JPH0153678B2 (en) | 1989-11-15 |
Family
ID=15637671
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP56156892A Granted JPS5857395A (en) | 1981-09-30 | 1981-09-30 | 2-amino-6-alkoxycarbonylmethylpurine nucleoside |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5857395A (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5533432A (en) * | 1978-09-01 | 1980-03-08 | Yamasa Shoyu Co Ltd | Production of 6-alkyl purine nucleoside |
-
1981
- 1981-09-30 JP JP56156892A patent/JPS5857395A/en active Granted
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5533432A (en) * | 1978-09-01 | 1980-03-08 | Yamasa Shoyu Co Ltd | Production of 6-alkyl purine nucleoside |
Also Published As
Publication number | Publication date |
---|---|
JPH0153678B2 (en) | 1989-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5633366A (en) | Pyrimidine nucleoside derivatives and methods for producing them | |
JPS5857395A (en) | 2-amino-6-alkoxycarbonylmethylpurine nucleoside | |
US4751293A (en) | Process for preparation of N6 -substituted 3',5'-cyclic adenosine monophosphate and salt thereof | |
Sakakibara et al. | Reaction of phenyl 2-0-acetyl-4, 5-0-benzylidene-3-deoxy-3-nitro-. beta.-D-glucopyranoside with alkali azide | |
JPS633875B2 (en) | ||
JPS63145296A (en) | Production of 5-trifluoromethyl-2'-deoxy-beta-uridines | |
JP3259191B2 (en) | Synthesis of 2,2'-anhydroarabinosyl thymine derivatives | |
Zecchini et al. | A new route to N2‐and N3‐substituted‐2, 3‐diaminopyridines. Synthesis of 1‐and 3‐alkoxycarbonyl‐v‐triazolo [4, 5‐b] pyridines | |
JP2770357B2 (en) | Method for producing nucleoside derivative | |
JP3703509B2 (en) | Method for producing D-mannosamine derivative | |
JPH0798833B2 (en) | 2'-Bromo-2 ', 3'-didehydro-2', 3'-dideoxycytidine and process for producing the same | |
JP2898326B2 (en) | Synthetic method of carbooxetanosin G | |
JPS62129292A (en) | Lipid a monosaccharide related substance developing biological activity | |
JPH03255081A (en) | Production of dl-griseofulvin, its derivative and intermediate thereof | |
JPS5859997A (en) | 2-amino-6-carbamoylmethylpurine nucleoside | |
JPH0269469A (en) | Dihydrofuran derivative and production thereof | |
JPH013194A (en) | 2'-Bromo-2',3'-didehydro-2',3'-dideoxycytidine and its production method | |
JPH01100147A (en) | Optically active malonic acid ester derivative | |
JPS5859998A (en) | Preparation of 2-fluoro-6-methylpurine nucleoside | |
CN118184571A (en) | Synthesis method of trelagliptin succinate impurity compound | |
JPH0154359B2 (en) | ||
JPS588093A (en) | 5-halogeno-3'-deoxyuridine and its preparation | |
US3954752A (en) | Process for preparing 2',3',5'-tri-0-acetyl-6-azauridine | |
JPS59163394A (en) | Preparation of 5-carboxyvinyluracil nucleoside | |
NO144887B (en) | PROCEDURE FOR THE PREPARATION OF 1- (TETRAHYDRO-2-FURYL) -5-FLUORURACIL, OF 1,3-BIS- (TETRAHYDRO-2-FURYL) -5-FLUORO-URACIL OR OF A MIXTURE OF THESE |